CompoAtlas

Korean Red Ginseng

Natural health product licensed in Canada

Licence holder
WN Pharmaceuticals Ltd
NPN or DIN-HM
80012591
Status
Active licence
Licence date
20 August 2009
Revision date
2 June 2022
Form
Caplet
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Panax ginseng

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 3:1

Dry plant equivalent : 276 mg

Potency : 6 % Total ginsenosides

92 mgNot calculated

Non-medicinal ingredients

Silice, Carbohydrate gum, Cellulose microcristalline, Glycérine, Stéarate de magnésium, Croscarmellose de sodium, Phosphate de calcium dibasique dihydraté

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Comprimé2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

(Used in Herbal Medicine as) supportive therapy for the promotion of healthy glucose levels. (Used in Herbal Medicine to) help(s) support cognitive function and/or reduce mental fatigue (in cases of mental stress). (Used in Herbal Medicine to) help(s) enhance capacity/physical performance (in cases of physical stress). Helps support cognition.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80012591

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line